Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Motilitone and Mosapride Combination in Functional Dyspepsia
NCT07096921Active, not recruiting
- Sponsor
- Eunpyeong St. Mary's Hospital
- Start
- Jul 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in functional dyspepsia (FD) comparing Mosapride + Motilitone with Mosapride + Placebo (2 arms). Primary endpoint: Proportion of overall responders at 4 weeks. Started Jul 2025; status: active, not recruiting.
02
Drugs
Motilitone
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT07096921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07096921.